Table 4.

Univariate analysis for the association between organ-based toxicities grade ≥3 and risk of event and death

EFSOS
HR (95% CI)PHR (95% CI)P
Cardiovascular-based complication 1.27 (0.55-2.91) .57 1.15 (0.38-3.42) .80 
Hematologic-based complication 2.24 (0.91-5.49) .08 1.35 (0.53-3.44) .54 
Metabolic-based complication 1.29 (0.66-2.52) .46 1.62 (0.66-3.96) .29 
Neurologic-based complication 1.14 (0.51-2.52) .75 1.66 (0.64-4.32) .30 
Pulmonary-based complication 2.28 (0.94-5.56) .07 2.92 (1.06-8.02) .04 
Infection-based complication 1.14 (0.53-2.47) .74 1.57 (0.62-3.93) .34 
CRS 1.95 (0.80-4.72) .14 2.43 (0.81-7.29) .11 
EFSOS
HR (95% CI)PHR (95% CI)P
Cardiovascular-based complication 1.27 (0.55-2.91) .57 1.15 (0.38-3.42) .80 
Hematologic-based complication 2.24 (0.91-5.49) .08 1.35 (0.53-3.44) .54 
Metabolic-based complication 1.29 (0.66-2.52) .46 1.62 (0.66-3.96) .29 
Neurologic-based complication 1.14 (0.51-2.52) .75 1.66 (0.64-4.32) .30 
Pulmonary-based complication 2.28 (0.94-5.56) .07 2.92 (1.06-8.02) .04 
Infection-based complication 1.14 (0.53-2.47) .74 1.57 (0.62-3.93) .34 
CRS 1.95 (0.80-4.72) .14 2.43 (0.81-7.29) .11 
Close Modal

or Create an Account

Close Modal
Close Modal